McCurdy, Keith
Butterfield, Jesse L.
Kwon, Hyejin
Gardner, Emily
Jordan, Madison
Ganser, Matthew
Mouncer, Michael J.
Osis, Jon
Clement, Christophe
Mudgil, Adarsh V.
Bruns, Carson J.
Funding for this research was provided by:
HYPRSKN Inc.
Article History
Received: 20 March 2026
Accepted: 23 June 2026
First Online: 2 July 2026
Declarations
:
: Study protocols were reviewed and approved by the TIER Institutional Review Board (IRB Registration Number IRB00012821, Parent Organization Number: IORG0010811). All participants provided written consent prior to participating in the study.
: Written informed consent was obtained from the participants for publication of their images.
: All co-authors have an interest in HYPRSKN Inc., a biotech startup that is the primary stakeholder of MGC INK CORP, the company responsible for Magic Ink as a commercial product.